Management of hearing in pediatric NF2

Otology and Neurotology

Volumn 33, Issue 6, 2012, Pages 1066-1070

  Shepard, Taylor H ^a   Tucci, Debara L ^a   Grant, Gerald A ^a   Kaylie, David M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Auditory brainstem implant; Bevacizumab; Cochlear implant; Hearing; Management of hearing; Neurofibromatosis type 2; Vestibular schwannoma

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY;

ADOLESCENT; ARTICLE; AUDITORY BRAIN STEM IMPLANT; CASE MANAGEMENT; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHILD; FEMALE; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; INNER EAR; MALE; MIDDLE CRANIAL FOSSA; MULTIMODALITY CANCER THERAPY; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PEROPERATIVE COMPLICATION; PONS ANGLE; RADIOTHERAPY;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; AUDITORY BRAIN STEM IMPLANTS; CASE MANAGEMENT; CEREBELLOPONTINE ANGLE; CHILD; COCHLEAR IMPLANTATION; COMBINED MODALITY THERAPY; CRANIAL FOSSA, MIDDLE; EAR, INNER; FEMALE; HEARING LOSS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MAGNETIC RESONANCE IMAGING; MALE; NEURILEMMOMA; NEUROFIBROMATOSIS 2; RADIOTHERAPY; STROKE;

EID: 84863984987     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182595325     Document Type: Article

References (20)

1. Asthagiri A, Parry D, Butman J. Neurofibromatosis type 2. Lancet 2009;373:1974-86.
2. Brackmann D, Fayad J, Slattery W. Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 2001;49:274-83.
3. Mautner V, Baser M, Thakkar S. Vestibular schwannoma growth in patients with neurofibromatosis type 2: A longitudinal study. J Neurosurg 2002;96:223-8.
4. Aristegui M, Denia A. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: Report of two cases (neurofibromatosis type 2 and unilater vestibular schwannoma). Otol Neurotol 2005;26:205-10.
5. Hoffman R, Kohan D, Cohen N. Cochlear implants in the mangagement of bilateral acoustic neuromas. Am J Otol 1992;13:525-8.
6. Neff B, Welling D. Current concepts in teh evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin N Am 2005;38: 671-84.
7. Otsuka G, Saito K, Nagatani T, Yoshida J. Age at symptom onset and long-term survival in patients with neurofibromatosis type 2. J Neurosurg 2003;99:480-3.
8. Mathieu D, Kondziolka D, Flickinger J. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 2007;60:460-8.
9. MacNally S, Rutherford S, King A. Outcome from surgery for vestibular schwannomas in children. Br J Neursurg 2009;23: 226-31.
10. Phi J, Kim D, Chung H. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2. Cancer 2009;115:390-8.
11. Slattery W, Fisher L, HItselberger W. Hearing preservation for neurofibromatosis type 2-related vestibular schwannoma in pediatric patients. J Neurosurg 2007;106:255-60.
12. Subach B, Kondziolka D, Lunsford L. Stereotactic radiosurgery in teh management of acoustic neuromas associated with neurofibromatosis type 2. J Neurosurg 1999;90:815-22.
13. Nunes F, MacCollin M. Neurofibromatosis 2 in the pediatric population. J Child Neurol 2003;18:718-24.
14. Plotkin S, Stemmer-Rachamimov A, Barker F. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009;361:358-67.
15. Sammii M, Matthies C, Tatagiba M. Management of schwannomas (acoustic neuromas): Auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 1997;40:696-706.
16. Vincenti V, Pasanisi E, Guida M, et al. Hearing rehabilitation in neurofibromatosis type 2 patients: Cochlear versus auditory brainstem implantation. Audiol Neurootol 2008;13:273-80.
17. Ahsan S, Telischi F, Hodges A, et al. Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection. Laryngoscope 2003;113:472-4.
18. Colletti V, Shannon R. Open set speech perception with auditory brainstem implant? Laryngoscope 2005;115:1974-8.
19. Neff B, Wiet R, Lasak J, et al. Cochlear implantation in the neurofibromatosis type 2 patient: Long-term follow-up. Laryngoscope 2007;117:1069-72.
20. Seki Y, Samejima N, Komatsuzaki A. Auditory brainstem implants: Current state and future directions with special reference to subtonsillar approach for implantation. Acta Neurochir 2007;97:431-5.